How steroids affect children with autoimmune conditions
Part of Bones, joints & muscles, Skin clinical trials.
This study talks to children and young people with autoimmune or inflammatory conditions (like juvenile arthritis) who have taken steroids in the past two years. It aims to understand how steroids impact their daily lives and feelings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 19 years old and have a rheumatology condition (like arthritis or lupus).
- You have taken steroid medication (by mouth or IV) for your condition within the last two years.
- You can understand and speak English well enough to discuss your experiences.
- You are able to agree to take part in an interview at the time it happens.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.
This study looks at how steroids affect bone health in people with inflammatory joint diseases like rheumatoid arthritis. Researchers will track markers in your blood to see if short-term steroid use impacts your bones.
This study looks at how steroid medicines (called glucocorticoids) affect bone strength in people with long-term inflammatory rheumatic conditions or psoriasis. It may help improve how doctors check and manage osteoporosis risk and bone metabolism over time.
This study follows children and teens who have an inflammatory rheumatism condition that started in childhood. It aims to better understand these illnesses and how they affect young people over time.
This study tests two ways of slowly lowering your steroid dose (prednisolone) to see which is safer and works better for people with stable rheumatoid arthritis. You may join if you have been on a low, steady dose of steroids and your arthritis is well controlled.
This trial studies whether it’s safer or works better to slowly reduce steroids versus stopping them abruptly after long-term use. It may help people who are currently on daily steroid tablets and don’t medically need a taper just to treat their underlying condition.
Hear when a new Rheumatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.